Identification of a Unique Glomerular Factor X Activator in Murine Lupus Nephritis
Subodini Perampalam, Edward Cole(University of Toronto), James F. Phillips(Columbia University), NIR STANIETSKY(University of Toronto), Jeffrey I. Weitz(McMaster University Medical Centre), Gary Levy(University Health Network), LUOQUAN WANG(University of Toronto), N Myers-Mason(University of Toronto), Cameron Ackerley(University of Toronto), JEN NEI YEOW
Cited by 2
Related Papers
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
|Journal of Clinical Investigation|1990|1.1k
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
|New England Journal of Medicine|2014|621